A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors MedImmune
- 21 Sep 2017 Planned End Date changed from 11 Aug 2017 to 2 Oct 2017.
- 21 Sep 2017 Planned primary completion date changed from 11 Aug 2017 to 2 Oct 2017.
- 21 Sep 2017 Status changed from recruiting to active, no longer recruiting.